A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase

RNA Biology

Volumn 2, Issue 3, 2005, Pages 86-92

  Iovino, Nicola ^a   Denti, Michela Alessandra ^b   Bozzoni, Irene ^b   Cortese, Riccardo ^a  

^a IRBM   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cre recombinase; Inducible shRNAs; Messanger knockdown; PolII promoter; RNAi; U1 promoter

Indexed keywords

CRE RECOMBINASE; ENZYME ACTIVATOR; LAMIN A; LAMIN C; RNA POLYMERASE II; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; ENZYME REPRESSION; GENE CASSETTE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; LOXP SITE; PROMOTER REGION; PROTEIN EXPRESSION; RNA INTERFERENCE; RNA SYNTHESIS; TRANSCRIPTION INITIATION SITE;

MAMMALIA;

EID: 30844465288     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.2.3.2045     Document Type: Article

References (36)

1. van der Krol AR, Mur LA, Beld M, Mol JN, Stuitje AR. Flavonoid genes in petunia: Addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell 1990; 2:291-9.
2. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391:806-11.
3. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296:550-3.
4. Kawasaki U, Taira K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res 2003; 31:700-7.
5. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002; 99:5515-20.
6. Denti MA, Rosa A, Sthandier O, De Angelis FG, Bozzoni I. A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther 2004; 10:191-9.
7. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, Clevers H. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4:609-15.
8. Matsukura S, Jones PA, Takai D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res 2003; 31:e77.
9. Gupta S, Schoer RA, Egan JE, Hannon GJ, Mittal V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci USA 2004; 101:1927-32.
10. Ohkawa J, Taira K. Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter. Hum Gene Ther 2000; 11:577-85.
11. Abremski K, Wierzbicki A, Frommer B, Hoess RH. Bacteriophage P1 Cre-loxP site-specific recombination. Site-specific DNA topoisomerase activity of the Cre recombination protein. J Biol Chem 1986; 261:391-6.
12. Sauer B, Henderson N. Crestimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 1989; 17:147-61.
13. Lakso M, Sauer B, Mosinger Jr B, Lee EJ, Manning RW, Yu SH, Mulder KL, Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 1992; 89:6232-6.
14. Hoess RH, Wierzbicki A, Abremski K. The role of the loxP spacer region in P1 site-specific recombination. Nucleic Acids Res 1986; 14:2287-300.
15. Sauer R, Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 1988; 85:5166-70.
16. Hoess R, Wierzbicki A, Abremski K. Isolation and characterization of intermediates in site-specific recombination. Proc Natl Acad Sci USA 1987; 84:6840-4.
17. Fritsch L, Martinez LA, Sekhri R, Naguibneva I, Gerard M, Vandromme M, Schaeffer L, Harel-Bellan A. Conditional gene knock-down by CRE-dependent short interfering RNAs. EMBO Rep 2004; 5:178-82.
18. Kasim V, Miyagishi M, Taira K. Control of siRNA expression using the Cre-loxP recombination system. Nucleic Acids Res 2004; 32:e66.
19. Tiscornia G, Tergaonkar V, Galimi F, Verma IM. From The Cover: CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci USA 2004; 101:7347-51.
20. Coumoul X, Li W, Wang RH, Deng C. Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res 2004; 32:e85.
21. Ventura A, Meissner A, Dillon CP, McManus M, Sharp PA, Van Parijs L, Jaenisch R, Jacks T. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci USA 2004.
22. Anton M, Graham FL. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: A molecular switch for control of gene expression. J Virol 1995; 69:4600-6.
23. De Angelis FG, Sthandier O, Berarducci B, Toso S, Galluzzi G, Ricci E, Cossu G, Bozzoni I. Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin premRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells. Proc Natl Acad Sci USA 2002; 99:9456-61.
24. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984; 81:1991-5.
25. Dirac AM, Bernards R. Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53. J Biol Chem 2003; 278:11731-4.
26. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000; 25:217-22.
27. Bernues J, Simmen KA, Lewis JD, Gunderson SI, Polycarpou-Schwarz M, Moncollin V, Egly JM, Mattaj IW. Common and unique transcription factor requirements of human U1 and U6 snRNA genes. Embo J 1993; 12:3573-85.
28. Hernandez N. Small nuclear RNA genes: A model system to study fundamental mechanisms of transcription. J Biol Chem 2001; 276:26733-6.
29. Schramm L, Pendergrast PS, Sun Y, Hernandez N. Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters. Genes Dev 2000; 14:2650-63.
30. Henry RW, Ford E, Mital R, Mittal V, Hernandez N. Crossing the line between RNA polymerases: Transcription of human snRNA genes by RNA polymerases II and III. Cold Spring Harb Symp Quant Biol 1998; 63:111-20.
31. Ringrose L, Lounnas V, Ehrlich L, Buchholz F, Wade R, Stewart AF. Comparative kinetic analysis of FLP and cre recombinases: Mathematical models for DNA binding and recombination. J Mol Biol 1998; 284:363-84.
32. Paddison PJ, Caudy AA, Sachidanandam R, Hannon GJ. Short hairpin activated gene silencing in Mammalian cells. Methods Mol Biol 2004; 265:85-100.
33. Zeng Y, Yi R, Cullen BR. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J 2005; 24:138-48.
34. Bordonaro M, Lazarova DL, Sartorelli AC. Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells. Nucleic Acids Res 2004; 32:2660-74.
35. Orban PC, Chui D, Marth JD. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci USA 1992; 89:6861-5.
36. Utomo AR, Nikitin AY, Lee WH. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat Biotechnol 1999; 17:1091-6.